Top-News
Gesundheitswesen USA

PolarityTE Inc News

Aktie
WKN:  A3DLAY ISIN:  US7310942070 US-Symbol:  RGTPQ
0,027 $
-0,0429 $
-61,37%
03.05.24 19:42:52
Handeln Depot/Watchlist
Aktienanzahl *
7,38 Mio.
Marktkapitalisierung *
481,64 Tsd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 04.04.2024

PolarityTE Inc News

27.12.22 - PR Newswire
PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company
PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company PR Newswire
10.11.22 - PR Newswire
PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update
PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update PR Newswire
09.11.22 - PR Newswire
PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company
PolarityTE Confirms Receipt of Unsolicited, Non-​Binding Offer to Acquire the Company PR Newswire
13.09.22 - PR Newswire
PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022
PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022 PR Newswire
11.08.22 - PR Newswire
PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update
PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update PR Newswire
01.08.22 - PR Newswire
PolarityTE to Report Q2 2022 Financial Results on August 11, 2022
PolarityTE to Report Q2 2022 Financial Results on August 11, 2022 PR Newswire
06.06.22 - PR Newswire
PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules
PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-​The-Market Under Nasdaq Rules PR Newswire
23.05.22 - PR Newswire
PolarityTE to Attend H.C. Wainwright Global Investment Conference
PolarityTE to Attend H.C. Wainwright Global Investment Conference PR Newswire
16.05.22 - PR Newswire
PolarityTE to Effectuate 1-for-25 Reverse Stock Split
PolarityTE to Effectuate 1-for-25 Reverse Stock Split PR Newswire
16.05.22 - PR Newswire
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update PR Newswire
06.05.22 - PR Newswire
PolarityTE to Report Q1 2021 Financial Results on May 16, 2022
PolarityTE to Report Q1 2021 Financial Results on May 16, 2022 PR Newswire
03.05.22 - PR Newswire
PolarityTE Announces First Subject Enrolled in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers
PolarityTE Announces First Subject Enrolled in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers PR Newswire
13.04.22 - PR Newswire
Thinking about buying stock in Agile Therapeutics, Polarityte, Bed Bath & Beyond, Tellurian, or Phio Pharmaceuticals?
Thinking about buying stock in Agile Therapeutics, Polarityte, Bed Bath & Beyond, Tellurian, or Phio Pharmaceuticals? PR Newswire
12.04.22 - PR Newswire
Thinking about buying stock in Polarityte, RLX Technology, Bitnile, Aterian, or Cyclacel Pharmaceuticals?
Thinking about buying stock in Polarityte, RLX Technology, Bitnile, Aterian, or Cyclacel Pharmaceuticals? PR Newswire
30.03.22 - PR Newswire
PolarityTE Reports Fiscal Year 2021 Financial Results and Provides Business Update
PolarityTE Reports Fiscal Year 2021 Financial Results and Provides Business Update PR Newswire
16.03.22 - PR Newswire
PolarityTE Announces Closing of $5.0 Million Registered Direct Offering
PolarityTE Announces Closing of $5.0 Million Registered Direct Offering PR Newswire
16.03.22 - PR Newswire
PolarityTE Announces $5.0 Million Registered Direct Offering
PolarityTE Announces $5.0 Million Registered Direct Offering PR Newswire
10.03.22 - PR Newswire
PolarityTE to Report Fiscal Year 2021 Financial Results on March 30, 2022
PolarityTE to Report Fiscal Year 2021 Financial Results on March 30, 2022 PR Newswire
18.01.22 - PR Newswire
Thinking about buying stock in Polarityte, Opko Health, Ion Geophysical, National CineMedia, or Playtika?
Thinking about buying stock in Polarityte, Opko Health, Ion Geophysical, National CineMedia, or Playtika? PR Newswire
18.01.22 - PR Newswire
PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication
PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication PR Newswire

Newssuche

Videos

newspaper
03.05.24 -13,45%
Technical Trading: Gold freitags Long
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »